Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam
Medical errors associated with IV preparation and administration procedures in a hospital workflow can even cost human lives due to the direct effect they have on patients. A large number of such incidents, which have been reported in bibliography up to date, indicate the urgent need for their preve...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-09-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/26/19/5879 |
| _version_ | 1797515951683403776 |
|---|---|
| author | Ioanna Chrisikou Malvina Orkoula Christos Kontoyannis |
| author_facet | Ioanna Chrisikou Malvina Orkoula Christos Kontoyannis |
| author_sort | Ioanna Chrisikou |
| collection | DOAJ |
| description | Medical errors associated with IV preparation and administration procedures in a hospital workflow can even cost human lives due to the direct effect they have on patients. A large number of such incidents, which have been reported in bibliography up to date, indicate the urgent need for their prevention. This study aims at proposing an analytical methodology for identifying and quantifying IV drugs before their administration, which has the potential to be fully harmonized with clinical practices. More specifically, it reports on the analysis of a piperacillin (PIP) and tazobactam (TAZ) IV formulation, using Raman spectroscopy. The simultaneous analysis of the two APIs in the same formulation was performed in three stages: before reconstitution in the form of powder without removing the substance out of the commercial glass bottle (non-invasively), directly after reconstitution in the same way, and just before administration, either the liquid drug is placed in the infusion set (on-line analysis) or a minimal amount of it is transferred from the IV bag to a Raman optic cell (at-line analysis). Except for the successful identification of the APIs in all cases, their quantification was also achieved through calibration curves with correlation coefficients ranging from 0.953 to 0.999 for PIP and from 0.965 to 0.997 for TAZ. In any case, the whole procedure does not need more than 10 min to be completed. The current methodology, based on Raman spectroscopy, outweighs other spectroscopic (UV/Vis, FT-IR/ATR) or chromatographic (HPLC, UHPLC) protocols, already applied, which are invasive, costly, time-consuming, not environmentally friendly, and require specialized staff and more complex sample preparation procedures, thus exposing the staff to hazardous materials, especially in cases of cytotoxic drugs. Such an approach has the potential to bridge the gap between experimental setup and clinical implementation through exploitation of already developed handheld devices, along with the presence of digital spectral libraries. |
| first_indexed | 2024-03-10T06:55:29Z |
| format | Article |
| id | doaj.art-de0ff7d73c0f4661869f4151660015fe |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-03-10T06:55:29Z |
| publishDate | 2021-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-de0ff7d73c0f4661869f4151660015fe2023-11-22T16:33:59ZengMDPI AGMolecules1420-30492021-09-012619587910.3390/molecules26195879Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and TazobactamIoanna Chrisikou0Malvina Orkoula1Christos Kontoyannis2Department of Pharmacy, University of Patras, University Campus, GR-26504 Rio Achaias, GreeceDepartment of Pharmacy, University of Patras, University Campus, GR-26504 Rio Achaias, GreeceDepartment of Pharmacy, University of Patras, University Campus, GR-26504 Rio Achaias, GreeceMedical errors associated with IV preparation and administration procedures in a hospital workflow can even cost human lives due to the direct effect they have on patients. A large number of such incidents, which have been reported in bibliography up to date, indicate the urgent need for their prevention. This study aims at proposing an analytical methodology for identifying and quantifying IV drugs before their administration, which has the potential to be fully harmonized with clinical practices. More specifically, it reports on the analysis of a piperacillin (PIP) and tazobactam (TAZ) IV formulation, using Raman spectroscopy. The simultaneous analysis of the two APIs in the same formulation was performed in three stages: before reconstitution in the form of powder without removing the substance out of the commercial glass bottle (non-invasively), directly after reconstitution in the same way, and just before administration, either the liquid drug is placed in the infusion set (on-line analysis) or a minimal amount of it is transferred from the IV bag to a Raman optic cell (at-line analysis). Except for the successful identification of the APIs in all cases, their quantification was also achieved through calibration curves with correlation coefficients ranging from 0.953 to 0.999 for PIP and from 0.965 to 0.997 for TAZ. In any case, the whole procedure does not need more than 10 min to be completed. The current methodology, based on Raman spectroscopy, outweighs other spectroscopic (UV/Vis, FT-IR/ATR) or chromatographic (HPLC, UHPLC) protocols, already applied, which are invasive, costly, time-consuming, not environmentally friendly, and require specialized staff and more complex sample preparation procedures, thus exposing the staff to hazardous materials, especially in cases of cytotoxic drugs. Such an approach has the potential to bridge the gap between experimental setup and clinical implementation through exploitation of already developed handheld devices, along with the presence of digital spectral libraries.https://www.mdpi.com/1420-3049/26/19/5879medical errorshospital workflowpatient safetyRaman spectroscopyIV drugspiperacillin |
| spellingShingle | Ioanna Chrisikou Malvina Orkoula Christos Kontoyannis Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam Molecules medical errors hospital workflow patient safety Raman spectroscopy IV drugs piperacillin |
| title | Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam |
| title_full | Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam |
| title_fullStr | Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam |
| title_full_unstemmed | Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam |
| title_short | Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam |
| title_sort | analysis of iv drugs in the hospital workflow by raman spectroscopy the case of piperacillin and tazobactam |
| topic | medical errors hospital workflow patient safety Raman spectroscopy IV drugs piperacillin |
| url | https://www.mdpi.com/1420-3049/26/19/5879 |
| work_keys_str_mv | AT ioannachrisikou analysisofivdrugsinthehospitalworkflowbyramanspectroscopythecaseofpiperacillinandtazobactam AT malvinaorkoula analysisofivdrugsinthehospitalworkflowbyramanspectroscopythecaseofpiperacillinandtazobactam AT christoskontoyannis analysisofivdrugsinthehospitalworkflowbyramanspectroscopythecaseofpiperacillinandtazobactam |